Analyst Conference Summaries

Biotechnology Investor Aids

Cidara Therapeutics

conference date: Ausust 12, 2021 press release only.

Coverage of Cidara conferences has not yet begun, though I started buying the stock in March 2021.

Cidara Therapeutics: Rezafungin Data Could Bring Value [Seeking Alpha, July 20, 2021]

Cidara Therapeutics Q1 2021 Press Release Cidara Therapeutics Q2 2021 Press Release    
May 13, 2021 Aug. 12, 2021    

Cidara Therapeutics (CDTX) is a clinical-stage biotechnology company specializing in therapies for viral and fungal infections.

Cidara Therapeutics web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers